VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Saturday, January 10, 2026
Stock Comparison
CSL Limited vs Elevance Health, Inc.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
CSL Limited
CSL · ASX
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Elevance Health, Inc.
ELV · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Elevance Health, Inc.'s moat claims, evidence, and risks.
View ELV analysisComparison highlights
- Moat score gap: CSL Limited leads (77 / 100 vs 74 / 100 for Elevance Health, Inc.).
- Segment focus: CSL Limited has 3 segments (71.7% in CSL Behring); Elevance Health, Inc. has 3 segments (85.2% in Health Benefits).
- Moat breadth: CSL Limited has 7 moat types across 3 domains; Elevance Health, Inc. has 8 across 3.
Primary market context
CSL Limited
CSL Behring
Plasma-derived therapies (immunoglobulins, albumin, coagulation factors) plus recombinant and gene therapies for rare and serious diseases
Global
Hospitals, specialty pharmacies, physicians; payers and national health systems
Vertically integrated biopharma (plasma collection -> fractionation/manufacturing -> commercial distribution)
71.7%
Elevance Health, Inc.
Health Benefits
U.S. health insurance and managed care
United States
Employers, individuals, and government programs
Payer / managed care organization
85.2%
Side-by-side metrics
Moat coverage
Shared moat types
CSL Limited strengths
Elevance Health, Inc. strengths
Segment mix
CSL Limited segments
Full profile >CSL Behring
Oligopoly
CSL Seqirus
Oligopoly
CSL Vifor
Oligopoly
Elevance Health, Inc. segments
Full profile >Health Benefits
Oligopoly
CarelonRx
Oligopoly
Carelon Services
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listLooking for expansion-stage stocks?
Proven models entering the expansion stage with unit economics that work.
View expansion-stage stocksCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.